A major breakthrough in genomics has been achieved by a collaborative team of researchers from Dante Omics AI, Rockefeller University, the Giunta Lab, Sapienza University, the University of Tennessee, Trieste Area Science Park, and the University of L’Aquila. The group successfully assembled a near-complete human diploid reference genome for the RPE-1 cell line, one of the most widely used cell lines in biomedical research worldwide. This achievement provides a high-quality, reference-grade genomic blueprint that significantly enhances the precision and reliability of experiments involving this critical model system. The RPE-1 cell line, derived from retinal pigment epithelial cells, has long served as a foundational tool in studies of cell biology, cancer, aging, and gene editing. However, until now, the genomic landscape of RPE-1 has been incomplete and inconsistent across laboratories, largely due to the lack of a comprehensive and accurate reference genome. Variations in genetic makeup between cell lines and the absence of a definitive diploid reference have hindered reproducibility and data interpretation in research. The new genome assembly, generated using advanced long-read sequencing technologies and sophisticated computational methods, resolves nearly all gaps in the previous versions. It captures both copies of each chromosome—reflecting the diploid nature of human cells—providing a more biologically accurate representation than earlier haploid or fragmented references. The team also identified structural variations, gene annotations, and repetitive regions with unprecedented clarity, offering a detailed map of the RPE-1 genome. Dante Omics AI played a pivotal role in the project, leveraging its expertise in genomic data analysis and AI-driven genome assembly through the Dante Labs platform. The integration of artificial intelligence with high-throughput sequencing enabled the team to overcome longstanding challenges in assembling complex regions of the genome, such as centromeres and telomeres, which are rich in repetitive sequences and difficult to resolve with traditional methods. This near-complete genome serves as a gold standard for the scientific community, allowing researchers to better understand genetic variation within RPE-1, validate CRISPR edits, and compare results across labs with greater confidence. It also opens new avenues for studying how genomic instability contributes to disease and aging, as well as for improving the accuracy of drug screening and gene therapy models. The publication of this reference genome is expected to have broad implications across biomedical research, particularly in fields such as regenerative medicine, oncology, and developmental biology. It also sets a precedent for generating high-quality reference genomes for other commonly used cell lines, potentially transforming how researchers approach reproducibility and data sharing. The collaborative effort underscores the growing importance of interdisciplinary partnerships between academic institutions, biotech firms, and AI-driven platforms in advancing genomics. By combining deep biological expertise with cutting-edge computational tools, the team has delivered a resource that will accelerate discovery and improve the reliability of laboratory research for years to come. This milestone represents a critical step toward a more precise and standardized future in cell line research, ensuring that scientific findings are built on a solid, well-characterized genomic foundation. As the use of human cell lines continues to expand in both academic and industrial settings, the availability of a reference-quality genome for RPE-1 will serve as an essential benchmark for innovation and reproducibility in life sciences.